Study shows improved schizophrenia negative symptoms with xanomeline‐trospium

depression, interpersonal sensitivity, hostility, obsession-compulsion, and somatization.Psilocybin-assisted therapy also did not induce lasting paranoia, phobia, or psychosis, with the study's authors writing that these findings add "further evidence that psilocybin can be safely administered following rigorous screening under close medical supervision." The researchers attributed the multidimensional effects of psilocybin in part to its action on the serotonin 2A receptor."While larger clinical trials will ultimately be needed to validate these findings, our study suggests that [psilocybin-assisted psychotherapy] has the potential to be a comprehensive mental health treatment for patients with cancer, " the authors wrote.[